España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Amgen
AMGN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$263.38
2.19
0.84%
At close: -
$263.38
0.00
0.00%
After Hours: Dec 20, 6:01 PM EDT
Get Report
Comment
Amgen (AMGN) Forecast
News
Earnings
Amgen (AMGN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Amgen (NASDAQ:AMGN) Stock
Amgen Stock (NASDAQ: AMGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 20, 2024
What's Going On With Amgen Stock On Friday?
Vandana Singh
CORRECTION: Amgen shares are trading higher. ...
Benzinga Newsdesk
Friday, December 13, 2024
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Vandana Singh
"Weight-Loss Drug Craze Appears To Be Curbing...
Benzinga Newsdesk
Thursday, December 12, 2024
Unpacking the Latest Options Trading Trends in Amgen
Benzinga Insights
Wednesday, December 11, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Tuesday, December 10, 2024
Amgen Boosts Q1 Dividend By 6% From $2.25 To ...
Benzinga Newsdesk
Demystifying Amgen: Insights From 13 Analyst Reviews
Benzinga Insights
B of A Securities Reinstates Underperform on ...
Benzinga Newsdesk
Saturday, December 07, 2024
Amgen Announced Blincyto Added To Chemotherap...
Benzinga Newsdesk
Thursday, December 05, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Amgen Announces A $1B Expansion To Establish ...
Benzinga Newsdesk
Tuesday, December 03, 2024
'ADA Advises Against Using Compounded GLP-1 R...
Benzinga Newsdesk
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
Surbhi Jain
Monday, December 02, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Wednesday, November 27, 2024
RBC Capital Maintains Outperform on Amgen, Lo...
Benzinga Newsdesk
Tuesday, November 26, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Stocks Mixed Ahead Of Fed Minutes, Mexican Peso Tumbles To Over 2-Year Lows On Tariff Fears: What's Driving Markets Tuesday?
Piero Cingari
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
Vandana Singh
Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau
Vandana Singh
Amgen shares are trading lower following the ...
Benzinga Newsdesk
Amgen Announced Data At 52 Weeks In Phase 2 S...
Benzinga Newsdesk
Thursday, November 21, 2024
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Surbhi Jain
Wednesday, November 20, 2024
Decoding Amgen's Options Activity: What's the Big Picture?
Benzinga Insights
Tuesday, November 19, 2024
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
Vandana Singh
Monday, November 18, 2024
Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Dow Tumbles Over 300 Points Following Economic Reports, Nvidia, Microsoft Decline: Fear & Greed Index Moves To 'Neutral' Zone
Avi Kapoor
Friday, November 15, 2024
Shares of pharmaceutical and healthcare stock...
Benzinga Newsdesk
Wolfe Research Initiates Coverage On Amgen wi...
Benzinga Newsdesk
Thursday, November 14, 2024
Amgen To Present MITIGATE Phase 3 Study At AC...
Benzinga Newsdesk
Amgen's Options Frenzy: What You Need to Know
Benzinga Insights
What Analysts Are Saying About Amgen Stock
Benzinga Insights
Citigroup Initiates Coverage On Amgen with Ne...
Benzinga Newsdesk
Wednesday, November 13, 2024
Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
Vandana Singh
Amgen Executive Says Co Continues To Be "Lase...
Benzinga Newsdesk
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Live On CNBC, Joe Terranova Announces Sold Am...
Benzinga Newsdesk
Amgen Issued The Statement On MariTide (Marid...
Benzinga Newsdesk
Jim Cramer Says Eli Lilly's 'Pathetic' Stock Performance Could Get A Breather If Amgen Has Hidden Bone Risk Data After 7% Stock Drop
Kaustubh Bagalkote
Tuesday, November 12, 2024
Jefferies Maintains Buy on Amgen, Maintains $...
Benzinga Newsdesk
Amgen shares are trading lower after Cantor F...
Benzinga Newsdesk
Cantor Fitzgerald Maintains Overweight Rating...
Benzinga Newsdesk
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Friday, November 08, 2024
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
Vandana Singh
Amgen And AstraZeneca Report Phase 3 Results:...
Benzinga Newsdesk
Tuesday, November 05, 2024
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
Vandana Singh
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Thursday, October 31, 2024
UBS Maintains Neutral on Amgen, Lowers Price ...
Benzinga Newsdesk
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
Piero Cingari
Wednesday, October 30, 2024
Amgen Sees FY24 EPS $19.20-$20.00 Vs $19.49
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch